How is Semax administered?
This describes how Semax is typically administered in clinical and research references, not a self-administration guide. The usual route is Intranasal spray (sub-q also used), on a 1-3x daily schedule, generally over 2-4 weeks on, equal time off. Specific dosing is individual and beyond general information, and human evidence for Semax is limited.
Administration at a glance (reference data)
- Route: Intranasal spray (sub-q also used)
- Schedule: 1-3x daily
- Cycle length: 2-4 weeks on, equal time off
- Half-life: ~30 minutes (intranasal)
References
- Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study) — Gusev EI, Skvortsova VI, Miasoedov NF, et al. Zh Nevrol Psikhiatr Im S S Korsakova, 1997
- Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophins and Their Receptor Genes after Cerebral Ischemia — Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Cellular and Molecular Neurobiology, 2009
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Semax
Last updated 2026-06-15.